Dual Antiplatelet Therapy vs Alteplase for Patients With Minor Nondisabling Acute Ischemic Stroke

Chen, Dawei; Cui, Yu; Zhou, Zhonghe; Zhang, Hong; Wang, Lixia; Wang, Weizhong; Shen, Liying; Guo, Liyan; Wang, Er-Qiang; Wang, Ruixian; Han, Jing; Dong, Yu-Ling; Li, Jing; Lin, Yongzhong; Yang, Qingcheng; Zhang, Li; Li, Jingyu; Wang, Jin; Xia, L.; Ma, Guang-Bin; Lu, Jiang; Jiang, Changhao; Huang, Shuman; Wan, Li-Shu; Piao, Hulin; Li, Zhuo; Li, Yansong; Yang, Kui-Hua; Wang, Duolao; N. Nguyen, Thanh; Investigators, ARAMIS; Gao, Zhuo; Zhao, Hang; Liu, Xiaodong; Liu, Xuewen; Zhang, Lihong; Zhang, Ling; Li, Li; Zhang, Jia-Dong; Wang, Xinqiang; Yang, Wenhai; Geng, Shi-Mei; Wang, Lian-Qiang; Li, Run-Hui

doi:10.1001/jama.2023.7827

Public

Dual Antiplatelet Therapy vs Alteplase for Patients With Minor Nondisabling Acute Ischemic Stroke

Published in JAMA • Jun 27, 2023

Authors:

Dawei Chen

Yu Cui

Zhonghe Zhou

Abstract

Importance: Intravenous thrombolysis is increasingly used in patients with minor stroke, but its benefit in patients with minor nondisabling stroke is unknown. Objective: To investigate whether dual antiplatelet therapy (DAPT) is noninferior to intravenous thrombolysis among patients with minor nond...

Subject

Medicine

Ischemic stroke

Minor stroke

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!